Leaps and the DLOM
January 2013 978-0615-60555-5 Softcover
Ron Seaman
Authored by Ron Seaman, LEAPS and the DLOM is an indispensable resource for every valuation practitioner. Ron has been studying the universe of Long-Term Equity Anticipation Securities (LEAPS) for five years to understand what they show about discounts for lack of marketability (DLOMs), which are key attributes in the valuation of closely-held shareholdings and other interests. Such discounts are frequently a significant reduction in the value of those holdings. Thus, courts and valuation practitioners are requiring better, market-based substantiation of the discounts. Leaps and the DLOM includes the 2010/11 Study and comparisons to earlier years, industry studies, and more LEAPS on Exchange Traded Funds (ETFs).
Table of Contents
- Foreward
- What is a DLOM?
- The four components. The "price at conversion." LEAPS show the cost of price protection
- What are LEAPS?
- How do they work?
- LEAPS Studies
- Purposes Of The Studies
- What is studied. Sources of the data. Discount calculations.
- 2010 LEAPS Studies: Financial Characteristics
- 2010 Study; Annual Comparisons
- Discounts By: Revenues Size; Total Assets Size; Dividend Yield;
- Company Beta; Profit Margin; Debt/Equity Ratio; Return On Equity
- 2010 LEAPS Studies: Industry Characteristics
- Discounts By: Industry Sector; Industry Sub-Category;
- Technology Industry; Healthcare Industry
- Purposes Of The Studies
- How fast do DLOMs change?
- How to use LEAPS
- LEAPS on ETFs (Exchange Traded Funds)
- Advantages and Disadvantages of LEAPS